pain

First Opinion By Shravani Durbhakula and Joshua M. Sharfstein

HHS needs to step up so CDC’s new guidelines won’t be ‘a bridge to nowhere’ for most Americans living with chronic pain

First Opinion By Antje M. Barreveld

As a pain specialist, I may have caused more harm by underprescribing opioids

The Readout LOUD By Adam Feuerstein and Meg Tirrell

Listen: What’s next for Roche, a debate over second boosters, & Vertex’s recent success

Biotech By Damian Garde

Vertex’s non-opioid painkiller meets goals in mid-stage studies

Health By Nicholas St. Fleur and Eric Boodman

STAT+ Conversation: Pain and Promise: Examining a fibromyalgia blood test

A STAT Investigation By Eric Boodman

Selling certainty: In a sea of skeptics, this physician was one of fibromyalgia patients' few true allies. Or was he?

Health Tech By Maddie Bender

5 health tech startups working to address chronic pain without opioids

Health By Claudia López Lloreda

In the same health system, Black patients are prescribed fewer opioids than white patients

Health By Elizabeth Cooney

Challenging the link between statins and muscle pain, patients report no difference in aches when taking drug or placebo

Health By Elizabeth Cooney

Elective, but not optional: Orthopedic patients eagerly await surgeries delayed by Covid-19

First Opinion By Vanila Singh

Misguided federal regulations are likely to cause more pain in people already living with it

In the Lab By Sharon Begley

Brain-imaging study shows ‘hot spot’ that may explain why African Americans feel greater pain

First Opinion By Daniel S. Goldberg

Pain doesn’t stigmatize people. We do that to each other

First Opinion By Nkeiruka Orajiaka

Some kids in pain need opioids. For doctors, that means walking a tightrope

In the Lab By Associated Press

U.S. awards $3 million to fill gaps in medical marijuana research

First Opinion By Dawn Rae Downton

Who is really behind a proposed new definition of pain?

Health By Lauren Joseph

Study: 2% of women have ‘persistent’ opioid use after childbirth

Health By Ruth Hailu

‘Sickle cell needs more funding’: An 18-year-old patient advocate calls on Washington to improve children’s health care

Special Report By Kaiser Health News

How the Kaiser-Johns Hopkins analysis was done

First Opinion By Ben Goodwin, Judy Butler and Adriane Fugh-Berman

Industry-funded attacks on the CDC’s opioid prescribing guideline are eroding public health

First Opinion By Julia Arnsten

Access to medical cannabis: a new health care disparity

First Opinion By William Fleischman and Joseph S. Ross

How Insys undermined an FDA effort to protect the public from dangerous opioids

Biotech By Damian Garde

Disappointing trial results dim hopes for a new class of pain drugs

Biotech By Damian Garde

How one company thinks unraveling cough can provide a new way to treat pain

In the Lab By Jacquelyn Corley

The case of a woman who feels almost no pain leads scientists to a new gene mutation